Company Quick10K Filing
Newfield Exploration
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-07-31
10-Q 2018-03-31 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-20
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-01
10-Q 2017-03-31 Filed 2017-05-02
10-K 2016-12-31 Filed 2017-02-21
10-Q 2016-09-30 Filed 2016-11-01
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-02-24
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-30
10-Q 2014-03-31 Filed 2014-04-30
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-07-26
10-Q 2013-03-31 Filed 2013-04-29
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-10-29
10-Q 2012-06-30 Filed 2012-07-26
10-Q 2012-03-31 Filed 2012-04-26
10-K 2011-12-31 Filed 2012-02-27
10-Q 2011-09-30 Filed 2011-10-21
10-Q 2011-06-30 Filed 2011-07-22
10-Q 2011-03-31 Filed 2011-04-25
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-10-22
10-Q 2010-06-30 Filed 2010-07-23
10-Q 2010-03-31 Filed 2010-04-30
10-K 2009-12-31 Filed 2010-02-26
8-K 2019-02-13
8-K 2019-02-12
8-K 2019-02-05
8-K 2019-01-29
8-K 2019-01-08
8-K 2018-12-14
8-K 2018-11-01
8-K 2018-10-31
8-K 2018-07-31
8-K 2018-07-26
8-K 2018-05-15
8-K 2018-05-01
8-K 2018-04-25
8-K 2018-03-23
8-K 2018-02-20
8-K 2018-02-14

Newfield Exploration Financials

NFX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2009-12-312010-06-302010-09-302011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash78122128567431762765612588445189951073639614783421013537165478555469522428326241339311
Accounts Receivable339328276333360322407481416427452408476441474384384395405354447263262245256210232243224277292327348386
Inventory848286931061079011010412513211010614616341413833272531343119221625191815232425
PP&E10,40611,41311,80312,83513,73014,35714,52614,73615,16615,61714,34614,74715,29715,92016,65015,29515,876
Assets6,2547,0087,2267,7168,4818,9038,9919,0379,8449,4317,9127,9288,3818,7439,3218,6518,9569,0689,5989,6787,4585,5134,7684,7774,2854,2134,3124,3884,5954,7444,9615,1225,4615,676
Accounts Payable83102817011397112707876696057877659516532629262414959373340448846525751
Long-Term Debt2,0372,1692,1692,4282,8892,9853,0062,9203,5953,1903,0453,0453,2763,4853,6943,0463,0773,0462,8923,1462,4502,4982,4672,4292,4302,4302,4312,4322,4322,4332,4342,4342,4352,436
Liabilities3,4863,8803,9264,3884,9195,0655,0714,9955,6535,2635,1325,1465,4745,8246,3655,4015,7145,5435,7055,4404,2013,4823,3893,2393,4133,2973,3743,2883,3883,4433,5533,6173,8213,805
Stockholders' Equity2,7683,1283,3003,3283,5623,8383,9204,0424,191
Income Statement ($MM)2009-12-312010-06-302010-09-302011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue711
Cost of Revenue
Gross Profit
R&D
SG&A414037445153456159534644586547515349545154
Tax5693-10128155287179-11573565-2151711156217-280-574-665-66-2941179-19-381314-6
Net Income96161-1721926968116135-33-1,402-81112717284235278360-480-992-1,227-663-624-667481314798879586119224
Cash Flow ($MM)2009-12-312010-06-302010-09-302011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating41930942044441621236322934335925148535036536833731720537231232072306209239167300173312260488349
Cash Investing-418-407-860-575-394-168-400-353-238-399-474-631-554297-47362-546-486-412-387-313-275-670116-162-251-242-261-414-376-390-365
Cash Financing51154588823-93666-407-142-4230184210-65034-39-1531,050-70140-9735-8-120-2-5-60-90-12